Influx Health is a contract development and manufacturing organization (CDMO) serving nutraceuticals, cosmetics, ayurveda, pet care, and ready-to-drink beverages, with 718+ clients and 98% retention. Growth is anchored on a new 75,000 sq ft facility expected operational by August 2026 that lifts installed capacity ~2.5x, plus new beverage lines (10,000 bottles/hour) and a pet food extrusion upgrade from 100 to 1,000 kg/hour. Management guides FY27 topline growth of 25–30% with EBITDA margins of 20–22%, and the new facility alone is expected to contribute ₹40–50 crore in H2 FY27. If capacity fills, revenue could scale to ₹450–500 crore by FY29, supported by export registrations in Tanzania, Nigeria, and Kenya and new categories like clinical nutrition and cosmetics. Key execution watchpoint is the commissioning timeline and gradual capacity absorption, given no long-term contracts and top clients contributing ~30–40% of revenue.
companyname: Influx Healthtech Limited ticker: INFLUX sector: Contract Development and Manufacturing Organization (CDMO) specializing in nutraceutical, cosmetic, pet care, home care, and ayurveda products Influx Healthtech is a contract development and manufacturing organization (CDMO) that takes a product from concept to commercial shelf. It does the formulation, manufacturing, packaging, and regulatory paperwork for nutraceuticals, cosmetics, ayurveda, pet care, and home care products. Its cu...
Read the full report →Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Influx Health. and 4,900+ companies.
5-day free pass. No card required.